NASDAQ:MBIO

Mustang Bio Stock Insider Trading

Healthcare > Biotechnology

Buy MBIO

*Your capital is at risk

$0.762

-0.0075 (-0.98%)

At Close: Jun 02, 2026

Mustang Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.58. In total, the insiders bought 11.71M and sold 53.57K MBIO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.58
● Buy	11.71M shares
● Sell	53.57K shares
80% Buy Activity Weak Negative Correlation
Sell Signal Low Confidence Jun 01, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 99.58. Confidence increased due to high data reliability score of 80.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 24, 2026 Sell	COMMON STOCK F-InKind	Litchman Manuel Md President, CEO And Interim CFO	CEO / President	19 Value: $14
Jan 02, 2026 Buy	COMMON STOCK, PAR VALUE $0.0001 A-Award	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	278 385 Value: $297.9K
Dec 30, 2025 Buy	COMMON STOCK, PAR VALUE $0.0001 P-Purchase	Jin David Director	Director	247 Value: $238
Dec 30, 2025 Sell	COMMON STOCK, PAR VALUE $0.0001 S-Sale	Chill Adam J. Director	Director	4 Value: $4
Dec 30, 2025 Sell	COMMON STOCK, PAR VALUE $0.0001 S-Sale	Herskowitz Neil Director	Director	247 Value: $238
Sep 29, 2025 Buy	COMMON STOCK, PAR VALUE $0.0001 A-Award	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	59 334 Value: $93.2K
Sep 29, 2025 Buy	COMMON STOCK, PAR VALUE $0.0001 A-Award	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	59 334 Value: $93.2K
Apr 24, 2025 Sell	COMMON STOCK F-InKind	Litchman Manuel Md President, CEO And Interim CFO	CEO / President	27 Value: $33
Apr 24, 2025 Sell	COMMON STOCK F-InKind	Litchman Manuel Md President, CEO And Interim CFO	CEO / President	27 Value: $33
Mar 31, 2025 Buy	COMMON STOCK, PAR VALUE $0.0001 A-Award	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	67 806 Value: $84.8K
Mar 31, 2025 Buy	COMMON STOCK, PAR VALUE $0.0001 A-Award	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	67 806 Value: $84.8K
Dec 31, 2024 Buy	COMMON STOCK, PAR VALUE $0.0001	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	0 Value: $0
Dec 31, 2024 Buy	COMMON STOCK, PAR VALUE $0.0001	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	0 Value: $0
Oct 23, 2024 Buy	Common Stock	Jin David Director	Director	0 Value: $0
Oct 23, 2024 Buy	Common Stock	Jin David Director	Director	0 Value: $0
Jun 27, 2024 Buy	COMMON STOCK, PAR VALUE $0.0001 A-Award	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	575 191 Value: $13.4M
Jun 27, 2024 Buy	COMMON STOCK, PAR VALUE $0.0001 A-Award	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	575 191 Value: $13.4M
May 31, 2024 Sell	Common Stock F-InKind	Litchman Manuel Md President And CEO	CEO / President	1 396 Value: $489
May 31, 2024 Sell	Common Stock F-InKind	Litchman Manuel Md President And CEO	CEO / President	1 396 Value: $489
Jan 19, 2024 Buy	Common Stock J-Other	Murphy James B Officer	Officer	0 Value: $0
Jan 19, 2024 Buy	Common Stock J-Other	Murphy James B Officer	Officer	0 Value: $0
Jan 02, 2024 Buy	COMMON STOCK, PAR VALUE $0.0001 A-Award	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	419 092 Value: $0
Jan 02, 2024 Buy	COMMON STOCK, PAR VALUE $0.0001 A-Award	Fortress Biotech, Inc. 10 Percent Owner	10% Owner	419 092 Value: $0
Dec 11, 2023 Buy	Common Stock	Carney Peter See Remarks	Officer	0 Value: $0
Dec 11, 2023 Buy	Common Stock	Carney Peter See Remarks	Officer	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MUSTANG BIO INC

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develo...

Read Full Profile Here